Cephalosporins with Pseudomonas Aeruginosa Coverage

Cephalosporins with Pseudomonas Aeruginosa Coverage


Identification: MSNJ2115
Issue: July-August 2021
Volume: Vol. 30/No. 4
Credits (Post Test and/or Evaluation Required)
Available until 08/31/2023
  • 1.30 - CH
  • 1.00 - Rx

Price: $20.00

Description

Learning Outcome:
After completing this education activity, the learner will be able to identify the key factors that influence clinical outcomes with antibiotic use.


Contact hours available until 8/31/2023.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online NCPD evaluation.

Authors Conflict of Interest Disclosure:
The author(s), editor, editorial committee, content reviewers, and education director reported no actual or potential conflict of interest in relation to this nursing continuing professional development article.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
This education activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.

This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, AMSN Education Director.

Author(s)

Credits Available


Cephalosporins with Pseudomonas Aeruginosa Coverage

You must be logged in and own this product in order to post comments.

Christine Sweeney
9/27/21 7:22 pm

Following the renal function is important to prevent toxicity